Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule

被引:93
作者
Brok, HPM
Uccelli, A
de Rosbo, NK
Bontrop, RE
Roccatagliata, L
de Groot, NG
Capello, E
Laman, JD
Nicolay, K
Mancardi, GL
Ben-Nun, A
't Hart, BA
机构
[1] Biomed Primate Res Ctr, Dept Immunobiol, NL-2288 GJ Rijswijk, Netherlands
[2] Univ Genoa, Dept Neurol Sci, Genoa, Italy
[3] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[4] Erasmus Univ, Dept Immunol, Rotterdam, Netherlands
[5] Univ Utrecht, Dept Expt In Vivo NMR, Image Sci Inst, Utrecht, Netherlands
关键词
D O I
10.4049/jimmunol.165.2.1093
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunization of common marmosets (Callithrix jacchus) with a single dose of human myelin in CFA, without administration of Bordetella pertussis, induces a form of autoimmune encephalomyelitis (EAE) resembling in its clinical and pathological expression multiple sclerosis in humans. The EAE incidence in our outbred marmoset colony is 100%, This study was undertaken to assess the genetic and immunological basis of the high EAE susceptibility. To this end, we determined the separate contributions of immune reactions to myelin/oligodendrocyte glycoprotein (MOG) and myelin basic protein to the EAE induction. Essentially all pathological features of myelin-induced EAE were also found in animals immunized with MOG in CFA, whereas in animals immunized with myelin basic protein in CFA clinical and pathological signs of EAE were lacking, The epitope recognition by anti-MOG Abs and T cells were assessed. Evidence is provided that the initiation of EAE is based on T and B cell activation by the encephalitogenic phMOG14-36 peptide in the context of monomorphic Caja-DRB*W1201 molecules.
引用
收藏
页码:1093 / 1101
页数:9
相关论文
共 30 条
  • [1] The common marmoset:: A new world primate species with limited Mhc class II variability
    Antunes, SG
    de Groot, NG
    Brok, H
    Doxiadis, G
    Menezes, AAL
    Otting, N
    Bontrop, RE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11745 - 11750
  • [2] Major histocompatibility complex class II polymorphisms in primates
    Bontrop, RE
    Otting, N
    de Groot, NG
    Doxiadis, GGM
    [J]. IMMUNOLOGICAL REVIEWS, 1999, 167 : 339 - 350
  • [3] EVOLUTION OF MAJOR HISTOCOMPATIBILITY COMPLEX POLYMORPHISMS AND T-CELL RECEPTOR DIVERSITY IN PRIMATES
    BONTROP, RE
    OTTING, N
    SLIERENDREGT, BL
    LANCHBURY, JS
    [J]. IMMUNOLOGICAL REVIEWS, 1995, 143 : 33 - 62
  • [4] Pertussis infection and vaccination induces Th1 cells
    Brady, MT
    Mahon, BP
    Mills, KHG
    [J]. IMMUNOLOGY TODAY, 1998, 19 (11): : 534 - 534
  • [5] T-cell responses to myelin antigens in multiple sclerosis; Relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein
    de Rosbo, NK
    Ben-Nun, A
    [J]. JOURNAL OF AUTOIMMUNITY, 1998, 11 (04) : 287 - 299
  • [6] de Rosbo NK, 1999, DECADE OF AUTOIMMUNITY, P169, DOI 10.1016/B978-044482824-8/50022-1
  • [7] LARGE-SCALE PREPARATION OF MYELIN BASIC PROTEIN FROM CENTRAL NERVOUS-TISSUE OF SEVERAL MAMMALIAN SPECIES
    DEIBLER, GE
    KIES, MW
    MARTENSON, RE
    [J]. PREPARATIVE BIOCHEMISTRY, 1972, 2 (02): : 139 - +
  • [8] REACTIVITY TO MYELIN ANTIGENS IN MULTIPLE-SCLEROSIS - PERIPHERAL-BLOOD LYMPHOCYTES RESPOND PREDOMINANTLY TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN
    DEROSBO, NK
    MILO, R
    LEES, MB
    BURGER, D
    BERNARD, CCA
    BENNUN, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2602 - 2608
  • [9] Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions
    deRosbo, NK
    Hoffman, M
    Mendel, I
    Yust, I
    Kaye, J
    Bakimer, R
    Flechter, S
    Abramsky, O
    Milo, R
    Karni, A
    BenNun, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) : 3059 - 3069
  • [10] Genain C. P., 1998, Journal of Neuroimmunology, V90, P34, DOI 10.1016/S0165-5728(98)91380-7